Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bluebird Bio
Bluebird Bio
Why bluebird and Celgene Should Worry About Amgen's Latest Clinical Victory
Motley Fool
Fri, 09/14/18 - 11:59 pm
Bluebird Bio
Amgen
Celgene
AMG-420
bb2121
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings
Yahoo/Benzinga
Mon, 09/3/18 - 01:09 pm
Adamis
GSK
Sangamo BioSciences
Roche
Bluebird Bio
ProQR Therapeutics
Geron
Amarin
Palatin
EyeGate
Galactin
Omeros
Atossa Genetics
Bluebird taps Gritstone for oncology cell therapy targets
Fierce Biotech
Thu, 08/23/18 - 11:04 am
Bluebird Bio
Gritstone Oncology
oncology
T-cell receptors
drug development
Express Scripts staking out million-dollar gene therapies
Reuters
Wed, 08/15/18 - 10:32 pm
Express Scripts
PBMs
gene therapies
drug pricing
Biomarin
Bluebird Bio
Spark Therapeutics
Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer
Forbes
Mon, 08/6/18 - 11:53 am
Regeneron
Bluebird Bio
CAR-T
drug discovery
gene therapy
cancer
Bluebird’s first gene therapy gets European fast track
PM Live
Sat, 07/28/18 - 12:26 pm
Bluebird Bio
gene therapy
EMA
LentiGlobin
Celgene tweaks trial of myeloma CAR-T bb2121, raising dose
Fierce Biotech
Fri, 07/13/18 - 09:44 am
Celgene
clinical trials
bb2121
Bluebird Bio
Multiple Myeloma
CAR-T
Why bluebird bio's Shares Have Tumbled 11.9% in 2018 So Far
Motley Fool
Mon, 07/9/18 - 10:48 am
Bluebird Bio
gene therapy
beta thalassemia
LentiGlobin
Evercore ISI Says Bluebird Bio Has Path To Commercialization, Madrigal Pharma Outpaced By Mid-Cap Alternatives
Yahoo/Benzinga
Sun, 06/24/18 - 09:32 pm
Bluebird Bio
Celgene
LentiGlobin
Madrigal Pharmaceuticals
Demand For Gene Therapies To Prompt Surge In Pharma M&A
Forbes
Tue, 06/19/18 - 10:11 pm
gene therapy
M&A
Bluebird Bio
Sangamo Therapeutics
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
CP Wire
Fri, 06/15/18 - 10:02 am
Bluebird Bio
sickle cell disease
LentiGlobin
gene therapy
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
CP Wire
Fri, 06/15/18 - 10:01 am
Bluebird Bio
gene therapy
LentiGlobin
beta thalassemia
sickle cell disease
Bluebird Bio Announces More Good News for LentiGlobin Gene Therapy – Exciting Results in Sickle Cell Disease
Fri, 06/15/18 - 09:51 am
Bluebird Bio
sickle cell disease
LentiGlobin
Bluebird Bio Presents Promising Results for Gene Therapy in Rare Blood Disorder
Fri, 06/15/18 - 09:39 am
Bluebird Bio
β-thalassemia
sickle cell disease
LentiGlobin
ASCO18: Who were the big winners and losers?
Biopharma Dive
Wed, 06/6/18 - 04:06 pm
ASCO 2018
Merck
Loxo Oncology
Bluebird Bio
Celgene
Roche
Nektar
#ASCO18: A Weekend of Surprises
Motley Fool
Sun, 06/3/18 - 09:13 pm
ASCO 2018
Bluebird Bio
Loxo Oncology
Nektar Therapeutics
Celgene
Grail
Bluebird Bio's "Impressive" Killer T-Cells Battle Myeloma, But Are Not A Cure Yet
Forbes
Fri, 06/1/18 - 10:48 pm
Bluebird Bio
CAR-T
Multiple Myeloma
bb2121
ASCO 2018
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Yahoo/Benzinga
Mon, 05/28/18 - 02:14 pm
ASCO 2018
European Society of Cardiology
TherapeuticsMD
Abiomed
Incyte
Bluebird Bio
Celgene
Syndax
Loxo Oncology
Exelixis
Karyopharm
Endocyte
Celldex Therapeutics
Jounce Therapeutics
Bristol-Myers Squibb
Nektar
Bluebird widens hunt for TCR therapies in revised Medigene deal
Biopharma Dive
Mon, 05/14/18 - 10:58 pm
Bluebird Bio
Medigene
CAR-T
bluebird bio Looks for Data Ahead
Motley Fool
Wed, 05/9/18 - 09:22 pm
Bluebird Bio
earnings
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »